When was GHB Biopharma Consulting founded?

GHB Biopharma Consulting was founded in 2019.

Where is GHB Biopharma Consulting located?

GHB Biopharma Consulting is headquartered in Konstanz, Germany.

Where does GHB Biopharma Consulting rank among its competitors?

GHB Biopharma Consulting ranks 1317th amongst 1402 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of GHB Biopharma Consulting?

GHB Biopharma Consulting's top competitors include Indegene, Clinigen and IntegriChain. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

GHB Biopharma Consulting - 2026 Company Profile & Competitors

Company Details

GHB Biopharma Consulting offers support for clinical development and medical affairs with a focus on inflammatory diseases, pharmacovigilance, and benefit/risk analysis. They have significant experience in the field of clinical development, medical affairs, and regulatory approvals.

Key Metrics

Founded Year

2019

Location

Konstanz, Germany

Stage

Unfunded

Ranked

1317^th among 1402 active competitors

Similar Companies

Indegene & 1661 more

View GHB Biopharma Consulting's full profile

GHB Biopharma Consulting has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GHB Biopharma Consulting include Indegene, Clinigen and IntegriChain. Here is the list of Top 10 competitors of GHB Biopharma Consulting, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 18 others	78/100
2nd	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
3rd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	58/100
4th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
5th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	57/100
6th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
7th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Bridgepoint Group, Baird Capital & 8 others	56/100
8th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
9th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
10th	Spectrum Pharmatech Consultants 1995, Thane (India), Unfunded	Provider of diversified consulting services for biopharma sector	-	-	49/100
1317th	GHB Biopharma Consulting 2019, Konstanz (Germany), Unfunded	Biopharma consulting company specializing in clinical development, medical affairs for inflammatory diseases, pharmacovigilance, and benefit/risk analysis	-	-	16/100